PriCara™: Phase 3 Study Compares Tapentadol Extended Release Tablets to Placebo in Patients With Chronic Low Back Pain
9/27/2010 8:54:54 AM
More...
|
PriCara™, Ortho-McNeil-Janssen Pharmaceuticals, Inc.: Phase 3 Open-Label Study Comparing Tapentadol Extended Release Tablets to Oxycodone Controlled Release Tablets Published by Pain Practice
7/19/2010 8:21:30 AM
More...
|
PriCara™'s Data Comparing NUCYNTA(R) (tapentadol) Tablets to Oxycodone Immediate Release Tablets Presented at 2010 American Pain Society
5/7/2010 10:44:50 AM
More...
|
PriCara™ Tapentadol Data to Be Presented at 2010 American Pain Society Annual Meeting
5/3/2010 12:27:39 PM
More...
|
PriCara™: NUCYNTA(TM) (tapentadol) CII Immediate Release Tablets Now Available for Relief of Moderate to Severe Acute Pain
6/23/2009 9:40:00 AM
More...
|
PriCara™ Recalls 50 mcg/hr DURAGESIC(R) (fentanyl transdermal system) CII Pain Patches
1/2/2009 6:46:02 AM
More...
|
PriCara™ Release: U.S. Federal Circuit Court of Appeals Rules Patent for ACIPHEX(R) Valid and Enforceable
7/22/2008 7:23:39 AM
More...
|
PriCara™ Recalls 25 mcg/hr DURAGESIC(R) (fentanyl transdermal system) CII Pain Patches
2/12/2008 11:23:48 PM
More...
|